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M
etastatic bone disease is a significant cause of morbidity and mortality in patients with advanced cancer. Bone is a common site of metastases for breast, lung, prostate, kidney, and thyroid cancer. Often these lesions result in pain, impaired mobility, hypercalcemia, pathologic fracture, and spinal cord compression. 1 Metastasis to the proximal femur is of particular concern because of the risk of pathologic fracture in a high-stress, weight-bearing structure. 2 Cemented proximal femoral replacement is an effective treatment for impending or completed pathologic fractures as a result of tumor metastasis. 1 Specifically, the use of methylmethacrylate with a proximal femoral prosthesis improves successful long-term stabilization of pathologic fractures, with less postoperative pain and early mobility. 3, 4 It has been postulated that long-stem devices protect the distal femur from supracondylar fracture because of a stress riser as a result of skip lesions or poor-quality femoral bone.
Although cemented femoral replacement offers protection and treatment of pathologic fractures with immediate weight bearing, it carries substantial This study attempted to determine whether patients undergoing cemented long-stem proximal femoral replacement had: (1) an increased short-term mortality rate; (2) greater intraoperative hemodynamic instability; (3) a greater need for resuscitation; and (4) a decreased risk of periprosthetic fracture. The current study reviewed intraoperative and short-term events related to clinical outcomes in 24 consecutive patients who were treated at a single institution over a 5-year period. These patients underwent primary long-stem (≥250 mm, n=13) vs short-stem (<250 mm, n=11) cemented proximal femoral replacement. Other than stem length, the 2 groups were not significantly different in terms of patient age, sex, height, weight, body mass index, diagnosis, or preoperative American Society of Anesthesiologists functional score. Primary outcomes were intraoperative death, blood loss, blood transfusions, fluid resuscitation, hypotension, oxygen desaturation, mortality up to 1 year, and need for revision surgery. At 1 year, a significantly increased mortality rate (77% vs 27%, P=.03) was noted in patients receiving long-stem vs shortstem arthroplasty. Patients who received longer stems also required more intraoperative blood transfusions and fluid resuscitation (P=.04) for greater hypotension (P=.04) and oxygen desaturation (P=.04). Two intraoperative deaths occurred in the long-stem group, and none occurred in the short-stem group. The findings suggest that there is an increased risk of intraoperative hemodynamic instability with long-stem vs short-stem proximal femoral replacement, with a need for greater resuscitative efforts and an increased risk of mortality at 1 year. [Orthopedics. 2016; 39(3):e423-e429.] risks. 5 Compared with uncemented hip arthroplasty, cemented arthroplasty is associated with fatty emboli, decreased cardiac output, increased pulmonary artery pressure, and pulmonary shunt. [6] [7] [8] In some cases, embolization has even led to cardiac arrest and intraoperative death. 9, 10 This phenomenon has classically been described as "cement implantation syndrome" and has been studied both clinically and in experimental animal models. Various explanations and mechanisms for the clinical manifestations of cement implantation syndrome have been proposed. 5, 6, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] The overall intraoperative death rate is low for cemented endoprostheses, but clearly, these numbers increase in patients with metastatic bone cancer. In a review of 30,714 patients undergoing total hip arthroplasty, 23 intraoperative deaths (0.06%) occurred. All deaths occurred in patients who had a cemented stem. Moreover, the death rate in this series increased to 4.3% when patients with metastatic bone cancer were examined. 25 High intramedullary pressures along a large cylindrical surface area of longstem endoprostheses during cementing are believed to enhance extravasation of microscopic fat, bone, cement, and tumor particles into the bloodstream. 3, 16, 19, 24, 26, 27 Extravasation of these substances into the bloodstream may be particularly significant in patients with cancer who have highly vascularized tumor beds as a result of bone metastases. 25 Several recent studies using transesophageal echocardiography confirmed an increase in the number and size of observed emboli immediately after pressurized cementing and reduction of the hip and found that these emboli result in reduced oxygen saturation and increased oxygen shunting. 7 However, to the authors' knowledge, the results with longer stems vs shorter stems have not previously been compared in terms of the risk of intraoperative hemodynamic instability requiring greater resuscitative efforts and the increased risk of intraoperative mortality and mortality 1 year postoperatively. 5, 28, 29 With pressurereducing techniques, thromboembolic phenomena along with hypotension and cardiac arrest may be decreased. 7, 30, 31 Cemented long-stem femoral implants have been associated with many of the clinical events discussed earlier (hypotension, desaturation, cardiac arrest, coma, and death) in as many as 62% of patients. 5, 29 In this series, the authors reported significantly more adverse events in patients undergoing primary cemented long-stem hip replacement than in those undergoing revision cemented long-stem hip replacement, suggesting that extrusion of canal contents during pressurization may be correlated with adverse outcomes. 29 The current study attempted to answer the following questions when comparing outcomes in patients who received longstem vs short-stem proximal femoral replacement: (1) Are long-stem devices associated with increased mortality during the first 12 months after surgery? (2) Do patients with longer stems have higher degrees of hemodynamic instability, as suggested in previous studies? (3) Do patients undergoing long-stem replacement require greater resuscitative efforts during surgery, including administration of blood and fluids? (4) Do patients with long-stem devices have an increased risk of periprosthetic fracture by 1 year?
Materials and Methods
An electronic medical records search was completed to identify all patients who underwent consecutive primary proximal femoral replacement at the Cleveland Clinic between 2008 and 2013. Strict selection criteria were used. For inclusion in the study, patients had to have undergone primary cemented proximal femoral replacement for either a primary or metastatic tumor with or without a pathologic fracture of the proximal femur ( Figure  1 ). All surgery was completed by 1 of 3 fellowship-trained orthopedic oncologists on staff at the Cleveland Clinic. Endoprostheses used were the Howmedica MRS Proximal Femur (Stryker, Mahwah, New Jersey), the Zimmer Segmental System (Zimmer, Warsaw, Indiana), and the Biomet Orthopedic Salvage System (Biomet, Warsaw, Indiana), based on surgeon preference. All cases involved resection of the proximal femur, and the resection level was based on tumor type and the extent of lesions. No distal venting or continuous suction lavage was used during implantation. All patients were monitored with continuous blood pressure measurements with an arterial line.
All 3 patients who had a diagnosis of metastatic renal cell carcinoma underwent preoperative angioembolization by interventional radiology before surgery. Only patients who had a complete intraoperative anesthesia report documented in the electronic medical record were included. Therefore, the search was limited to patients treated in 2008 and later because of the lack of uniform data before 2008. The study excluded patients who had undergone previous surgery (with the exception of a biopsy) to the ipsilateral proximal femur in the previous 5 years and patients who required removal of hardware at the time of surgery. In addition, patients who had radiographic or other evidence of metastasis to the ipsilateral distal femur at the time of surgery were excluded because of the potential for increased complexity of the case independently. One patient was excluded in this manner, and thus no patients included in the statistical analysis in either group had radiographic evidence of distal femoral metastases. Patients were not excluded from statistical analysis for the most common stated reason for using a longer stem, which was the surgeon's belief that the bone appeared weak. In total, 24 proximal femurs from 23 patients were included in the study. A shorter proximal femoral replacement was defined as an implant with a stem length less than or equal to 250 mm. The standard Howmedica proximal femoral stem is 127 mm. The authors reasoned that if stem length contributed to short-term adverse outcomes, it would do so in a dose-dependent manner. The longer the stem, the more cement would be pressurized over a larger cylindrical area in the medullary canal. Therefore, the authors selected the median stem length (250 mm) as the cutoff. Patient age, sex, height, weight, body mass index, and diagnosis were recorded, in addition to preoperative American Society of Anesthesiologists functional score as a measure of perioperative risk (Tables 1-2 ). All patients underwent preoperative evaluation by the internal medicine department and a trained anesthesiologist. Total blood loss, volume of packed red blood cells, volume of total intraoperative fluids, lowest systolic blood pressure, and lowest oxygen saturation were recorded. Also included were the lowest partial pressure of oxygen values and highest lactate levels from arterial blood gas measurements intraoperatively.
A total of 12 men and 12 women were included in the study, with an average age of 65.9 years (range, 30-89 years). All patients had an American Society of Anesthesiologists score of 3 to 4, indicating at least 1 severe systemic disease that is often a threat to life. Of these patients, 3 had a history of pulmonary embolism or deep venous thrombosis. The American Society of Anesthesiologists score was not significantly different in those receiving long stems vs short stems (3.46 vs 3.18, respectively; P=.16). Proximal femoral replacement was indicated in 22 patients for a metastatic tumor, and 2 patients had a primary bone or cartilage tumor. All patients were diagnosed as having a completed or impending pathologic fracture at the time of surgery. A catastrophic intraoperative event was defined as intraoperative death. Date of death was recorded for all patients who died within 1 year of surgery. The cause of death was not available for all patients, and so this information was not included in the reported data.
Statistical analysis was performed with Student's t test and the chi-square test for categorical data. For evaluation of 
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Copyright © SLACK inCorporAted n Feature Article the Kaplan-Meier survival curve, the logrank (Mantel-Cox) test was used to determine significance and derive proportional hazards. Analysis was conducted with GraphPad Prism version 6.00 for Apple OS X (GraphPad Software, La Jolla California; www.graphpad.com). P<.05 was considered significant.
results
Long-stem proximal femoral replacement is associated with an increased short-term mortality rate. At 1 year, a statistically significant (P=.03) approximately 3-fold increase in the mortality rate was seen in patients who underwent long-stem vs short-stem proximal femoral replacement. In addition, 2 of the 13 patients who had long-stem proximal femoral replacement died intraoperatively. At autopsy, both patients who died had evidence of numerous microscopic fat emboli with sectioning of the lung tissue. One patient had evidence of a large obstructive saddle embolus, and the second had abundant microemboli seen on lung tissue sectioning. All 11 patients who received short stems survived surgery. Of the 11 patients in the short-stem group, 3 (27%) were dead at 1 year compared with 10 of 13 patients (77%) in the long-stem group. A KaplanMeier survival curve showed increased mortality up to 1 year postoperatively (Figure 2) , and a log-rank test showed a statistically significant difference between the 2 curves (P=.03). Hazard ratios for mortality at 1 year were 3.69 (95% confidence interval, 1.17-12.84) for patients who received long-stem devices and 0.271 (95% confidence interval, 0.077-0.854) in those who received short-stem devices. Even when the 2 patients with shorter stems who had primary sarcoma and thus might be expected to have longer survival than patients with metastatic bone disease were removed from analysis, chi-square analysis showed a significantly increased risk of death within 1 year in patients with long-stem devices (P=.041).
Patients undergoing long-stem proximal femoral replacement have greater hemodynamic instability during surgery. Comparison of markers of hemodynamic stability between the long-stem and shortstem groups showed a statistically significant difference in lowest systolic blood pressure (P=.04) and oxygen saturation (P=.04) ( Table 3) . Estimated blood loss was not statistically significant in the 2 groups (P=.13). Blood loss was recorded in the electronic medical record after each case. Although the finding was not statistically significant, patients undergoing Impending pathologic fracture, No. 5 2 Table 2 Preoperative Diagnoses
No. short-stem replacement lost an average of 536 mL blood, whereas those undergoing long-stem cemented arthroplasty lost 1377 mL blood (P=.13). Estimated blood loss was determined by the surgeon and the anesthesiologist subjectively and varied greatly from case to case. All patients underwent placement of an arterial line, and dynamic intraoperative measurements of blood pressure were obtained throughout each surgical procedure. The lowest recorded systolic blood pressure was included. On average, in patients with shorter stems, the lowest systolic blood pressure was higher than that in patients receiving longer stems (92 mm Hg vs 81 mm Hg, respectively; P=.04). In nearly all patients, the period of greatest hypotension occurred several minutes after pressurized cementing. Oxygen saturation was dynamically measured throughout each case, and the lowest value was recorded. Oxygen saturation was significantly higher in patients receiving shorter stems compared with the value in those with longer stems (95.5% vs 90.2%, respectively; P=.04). Arterial blood gas measurements were obtained in patients who had desaturation or hemodynamic instability during surgery. Those who were stable throughout surgery did not have blood gas measurements. Additionally, the anesthesiology teams were not aware of the stem length used in each case. However, in 6 of 11 patients who received shorter stems and 13 of 13 patients who received longer stems, blood gas measurements were obtained, although the anesthesiology teams had no knowledge of the implant length. Average serum lactate measurements in those with short stems vs long stems were 1.6 and 2.2, respectively (P=.26).
Diagnosis
Patients receiving long-stem proximal femoral replacement required more blood transfusions and fluids during surgery than patients receiving short-stem implants. A statistically significant increase was found in the requirement for allogeneic blood transfusions and fluid resuscitation in patients undergoing long-stem implant surgery ( Table 3) . Anesthesia records were searched for total allogeneic blood volume given during each case. On average, patients undergoing long-stem proximal femoral replacement were given 985 mL vs 282 mL in the short-stem group (P=.04). In fact, 6 of 11 (54%) patients who received shorter stems received no allogeneic blood transfusions, whereas 12 of 13 (92%) patients receiving longer stems received blood during the case. Total volume of fluids administered (excluding blood or blood products) was also recorded, and patients were administered less crystalloid and colloid if they received a shorter stem vs a longer stem, on average (3850 mL vs 5000 mL, respectively; P=.04).
In this series, no cases of supracondylar femur fracture occurred in patients receiving short-stem implants at 1 to 4 years of follow-up. Follow-up records of patients undergoing long-stem and shortstem arthroplasty were examined, and rehospitalizations were noted ( Table 4) . No patients undergoing short-stem arthroplasty required revision surgery for periprosthetic fracture. One markedly obese patient in the short-stem group underwent revision surgery because of catastrophic failure and fracture of the implant at the base of the stem. The failed implant was replaced with an identical short-stem implant without the need for additional bony fixation. In the short-stem group, 1 patient had recurrent dislocations and a prosthetic joint infection with methicillinsusceptible Staphylococcus aureus that required revision surgery.
discussion
In the current study, 2 patients in the long-stem group died of what were later confirmed to be pulmonary embolism and microemboli in the lung parenchyma that led to cardiac arrest. These emboli occurred shortly after cement pressurization and implantation of the stem. Intraoperative death during long-stem hip arthro- Table 4 Postoperative Readmissions
No. n Feature Article plasty is rare, with some series reporting rates of as low as 0.06%. 10, 25, 29, 31 However, in the current study, patients underwent resection of the entire proximal femur, a more complex procedure that requires larger exposure and more blood loss. The rate of intraoperative death in patients receiving long stems vs short stems (2 vs 0, respectively) was not statistically significant. However, patients were also followed for 1 year, and Kaplan-Meier survival curves suggest a correlation between longer stem length and increased 1-year mortality. The underlying mechanism for the significantly increased mortality rate (P=.03) 1 year after long-stem proximal femoral replacement is unclear. Several studies showed that marrow fat is not the only substance that is extruded into the venous circulation during cement pressurization. 3, 7, 26, 32 Bone particles, tumor cells, and methylmethacrylate have been found in samples of venous blood after cementing and autopsy in both humans and animal models. 3, 7, 11, 26, 32 For up to 2 days after standard cemented total hip arthroplasty, pulmonary function is clinically compromised, with a significant increase in pulmonary shunt. 7, 8, 33 During surgery, greater hemodynamic instability occurred in patients who received longer stems. Estimated blood loss, although not significant, was more than twice as great in patients receiving longer stems vs shorter stems. Hypotension and oxygen desaturation were statistically greater in the long-stem group. Hemodynamic instability during and after surgery has been observed in numerous reports, with 1 report showing a need for prolonged intubation in up to 11% of patients. 29, 31, 33 In the current study, hemodynamic instability led to a more aggressive approach to resuscitation, with more blood and fluids. A recent prospective randomized study comparing cemented and uncemented standard hip hemiarthroplasty in the elderly showed no overall difference in mortality up to 1 year but reported 92 mL greater blood loss in the cemented group. 34 The current study suggests an effect with proximal femoral replacement based on the length of the femoral stem. Further studies are needed to address this interesting question.
Cause of Readmission
A prevailing indication for the use of a longer stem is to protect the remaining femur from subsequent fracture. The shorter stem can theoretically act as a stress riser or provide an unprotected site for subsequent metastasis through which fracture can occur. The current series had no observed cases of supracondylar or other ipsilateral femur fracture with short-stem or long-stem implants. The study excluded 1 patient with evidence of a distal metastatic lesion who went on to have implantation of a long-stem device without subsequent fracture. Alvi and Damron 28 examined this problem and showed that the progression of distal femoral metastatic lesions in patients with myeloma and lymphoma was lower than the extremely high 1-year mortality and overall complication rates of 80% that they reported. As discussed by Price et al, 33 given the high mortality and comorbidity rates in this population, protecting the femur if there is no significant distal lesion may not impart any relative benefit. No patients in the current study had progression of disease in the ipsilateral femur. Other reasons for readmissions occurred as anticipated in this population and included 2 cases of progression of known metastatic disease to other bony sites, including the humerus and the thoracic spine.
Limitations
The greatest limitation of this study was the sample size. Uniformity of subjects was maintained by limiting the study to consecutive patients who required proximal femoral replacement. The study excluded patients who required hardware removal or had undergone previous ipsilateral hip surgery in the past 5 years. Further studies are needed to confirm the benefit of shorter vs longer femoral replacement stems, but the current findings suggest that there may be less benefit and more risk associated with the use of a longer proximal femoral implant stem (>250 mm) than previously thought.
conclusion
This study suggests an increased risk of intraoperative hemodynamic instability with long-stem vs short-stem proximal femoral replacement, with a need for greater resuscitative efforts and an increased risk of mortality at 1 year.
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